What is Alto Neuroscience's investing cash flow?

Alto Neuroscience (ANRO) reported investing cash flow of -$556K in Q1 2026.

How has Alto Neuroscience's investing cash flow changed year-over-year?

Alto Neuroscience's investing cash flow decreased by 2216.7% year-over-year, from -$24K to -$556K.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Alto Neuroscience ANRO Investing Cash Flow

Investing Cash Flow at other companies

Xenon PharmaceuticalsXENE

-$407.28M-1,280%

Acadia PharmaceuticalsACAD

$66.28M+153%

Rapport Therapeutics, Inc.RAPP

$37.94M+80.4%

Praxis Precision Medicines, Inc.PRAX

-$344.28M-574%

MeiraGTx Holdings plcMGTX

-$2.26M-32.0%

LBR

LB Pharmaceuticals Inc Common StockLBRX

-$32K-101%

Other financials

Income statement

See full

Operating income-$27.1M-73.1%

Net income-$26.2M-73.0%

EPS (diluted)-$0.80-42.9%

Balance sheet

See full

Cash & equivalents$264.3M+63.9%

Total debt$20.9M-17.2%

Total equity$243.4M+75.0%

Total assets$276.3M+60.7%

Cash flow

See full

Operating cash flow-$27.1M-63.6%

CapEx$556.0K+2,217%

Free cash flow-$27.6M-66.7%

Valuation

See full

Market cap$887.88M+1,358%

Enterprise value$644.49M-958%

Returns & leverage

See full

Return on equity-38.9%+0.9pp

Debt / equity0.1×-0.1×

Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alto Neuroscience's investing cash flow?: Alto Neuroscience (ANRO) reported investing cash flow of -$556K in Q1 2026.
How has Alto Neuroscience's investing cash flow changed year-over-year?: Alto Neuroscience's investing cash flow decreased by 2216.7% year-over-year, from -$24K to -$556K.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.